Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT DIMEGLUMINE Cause Erythema? 35 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Erythema have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 3.9% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.

35
Reports of Erythema with FOSAPREPITANT DIMEGLUMINE
3.9%
of all FOSAPREPITANT DIMEGLUMINE reports
1
Deaths
9
Hospitalizations

How Dangerous Is Erythema From FOSAPREPITANT DIMEGLUMINE?

Of the 35 reports, 1 (2.9%) resulted in death, 9 (25.7%) required hospitalization, and 3 (8.6%) were considered life-threatening.

Is Erythema Listed in the Official Label?

Yes, Erythema is listed as a known adverse reaction in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE.

What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?

Dyspnoea (142) Pyrexia (136) Nausea (130) Infusion related reaction (83) Diarrhoea (80) Vomiting (71) Rash (66) Hypersensitivity (65) Stomatitis (64) Decreased appetite (62)

What Other Drugs Cause Erythema?

ADAPALENE (38,965) AVOBENZONE\OCTISALATE\OCTOCRYLENE (30,872) DUPILUMAB (10,877) ADALIMUMAB (4,829) ETANERCEPT (3,733) AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (3,462) INFLIXIMAB (2,919) METHOTREXATE (2,835) SECUKINUMAB (2,824) RITUXIMAB (2,460)

Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Erythema Risk?

FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT DIMEGLUMINE vs FOSCARNET FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL

Related Pages

FOSAPREPITANT DIMEGLUMINE Full Profile All Erythema Reports All Drugs Causing Erythema FOSAPREPITANT DIMEGLUMINE Demographics